Citius and longius (faster and longer) with no α-actinin-3 in skeletal muscles? | British Journal of Sports Medicine

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

For authors

Resources

About

New editors
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Responses

Case Report

Citius and longius (faster and longer) with no α-actinin-3 in skeletal muscles?

Compose a Response to This Article

Compose Response

Title *

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

No

Please describe the competing interests

PLEASE NOTE:

A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.

I agree to and have read the terms and conditions for rapid responses and BMJ Privacy Notice *

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

ACTN3 was never ‘the’ gene for speed
Stephen M. Roth
Published on: 11 October 2022

Published on: 11 October 2022
ACTN3 was never ‘the’ gene for speed
- Stephen M. Roth, Assistant Professor
Dear Editor,
Lucia and colleagues [1] recently reported a case study in which a Spanish elite long jumper was identified as being α-actinin-3 deficient, owing to carrying the X/X genotype of the R577X polymorphism in the ACTN3 gene. The authors suggest that the case provides a “notable” exception to the idea that ACTN3 represents “the ‘gene for speed’,” taking out of context a question posed in a recent review b...
Show More

Dear Editor,
Lucia and colleagues [1] recently reported a case study in which a Spanish elite long jumper was identified as being α-actinin-3 deficient, owing to carrying the X/X genotype of the R577X polymorphism in the ACTN3 gene. The authors suggest that the case provides a “notable” exception to the idea that ACTN3 represents “the ‘gene for speed’,” taking out of context a question posed in a recent review by MacArthur and North [2]. In their review, MacArthur and North consider the evidence for ACTN3 as ‘a’ potential gene important for muscle power performance, and in fact emphasize the “subtle effect” and “apparent benefit” for the gene on performance. Such words reflect the fact that muscle power and power- related performance are undoubtedly highly complex traits, governed by multiple genetic and environmental factors [3]. That ACTN3 may be a contributing gene for speed/power is certainly supported by several studies [4]. A notable feature of the present case is that it is the only elite-level strength or power athlete reported to date to be α- actinin-3 deficient [5, 6], providing indirect support for the hypothesis that α-actinin-3 is an important contributor to muscle power performance.
Stephen M. Roth, Ph.D. Department of Kinesiology University of Maryland College Park, MD 20742
References
1. Lucia, A, J Olivan, F Gomez-Gallego, C Santiago, M Montil, and C Foster. Citius and longius (faster and longer) with no alpha- actinin-3 in skeletal muscles? Br J Sports Med 2007; 41: 616-617.
2. MacArthur, DG and KN North. A gene for speed? The evolution and function of alpha-actinin-3. Bioessays 2004; 26(7): 786-95.
3. Beunen, G and M Thomis. Gene powered? Where to go from heritability (h2) in muscle strength and power? Exerc Sport Sci Rev 2004; 32(4): 148-54.
4. MacArthur, DG and KN North. ACTN3: A genetic influence on muscle function and athletic performance. Exerc Sport Sci Rev 2007; 35(1): 30-4.
5. Yang, N, DG MacArthur, JP Gulbin, AG Hahn, AH Beggs, S Easteal, et al. ACTN3 genotype is associated with human elite athletic performance. Am.J.Hum.Genet. 2003; 73: 627-631.
6. Niemi, AK and K Majamaa. Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet 2005; 13(8): 965-9.
Show Less

Conflict of Interest:
None declared.
- Back to top